Cargando…
Author Correction: Topical application of an irreversible small molecule inhibitor of lysyl oxidases ameliorates skin scarring and fibrosis
Autores principales: | Chaudhari, Nutan, Findlay, Alison D., Stevenson, Andrew W., Clemons, Tristan D., Yao, Yimin, Joshi, Amar, Sayyar, Sepidar, Wallace, Gordon, Rea, Suzanne, Toshniwal, Priyanka, Deng, Zhenjun, Melton, Philip E., Hortin, Nicole, Iyer, K. Swaminathan, Jarolimek, Wolfgang, Wood, Fiona M., Fear, Mark W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832150/ https://www.ncbi.nlm.nih.gov/pubmed/36627321 http://dx.doi.org/10.1038/s41467-023-35849-x |
Ejemplares similares
-
Topical application of an irreversible small molecule inhibitor of lysyl oxidases ameliorates skin scarring and fibrosis
por: Chaudhari, Nutan, et al.
Publicado: (2022) -
Coherency image analysis to quantify collagen architecture: implications in scar assessment
por: Clemons, T. D., et al.
Publicado: (2018) -
Pan-Lysyl Oxidase Inhibitor PXS-5505 Ameliorates Multiple-Organ Fibrosis by Inhibiting Collagen Crosslinks in Rodent Models of Systemic Sclerosis
por: Yao, Yimin, et al.
Publicado: (2022) -
Lysyl oxidase inhibitors attenuate cyclosporin A-induced nephropathy in mouse
por: Nguyen, Long T., et al.
Publicado: (2021) -
The lysyl oxidase like 2/3 enzymatic inhibitor, PXS‐5153A, reduces crosslinks and ameliorates fibrosis
por: Schilter, Heidi, et al.
Publicado: (2018)